NO20005290L - Riluzol- og levodopa kombinasjoner for behandling av Parkinsons sykdom - Google Patents
Riluzol- og levodopa kombinasjoner for behandling av Parkinsons sykdomInfo
- Publication number
- NO20005290L NO20005290L NO20005290A NO20005290A NO20005290L NO 20005290 L NO20005290 L NO 20005290L NO 20005290 A NO20005290 A NO 20005290A NO 20005290 A NO20005290 A NO 20005290A NO 20005290 L NO20005290 L NO 20005290L
- Authority
- NO
- Norway
- Prior art keywords
- riluzole
- disease
- parkinson
- treatment
- levodopa
- Prior art date
Links
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 title abstract 2
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 title abstract 2
- 208000018737 Parkinson disease Diseases 0.000 title abstract 2
- FTALBRSUTCGOEG-UHFFFAOYSA-N Riluzole Chemical compound C1=C(OC(F)(F)F)C=C2SC(N)=NC2=C1 FTALBRSUTCGOEG-UHFFFAOYSA-N 0.000 title abstract 2
- 229960004502 levodopa Drugs 0.000 title abstract 2
- 229960004181 riluzole Drugs 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9805153A FR2777781B1 (fr) | 1998-04-24 | 1998-04-24 | Associations riluzole et l-dopa pour le traitement de la maladie de parkinson |
| PCT/FR1999/000953 WO1999055336A1 (fr) | 1998-04-24 | 1999-04-22 | Associations de riluzole et de levodopa pour le traitement de la maladie de parkinson |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20005290D0 NO20005290D0 (no) | 2000-10-20 |
| NO20005290L true NO20005290L (no) | 2000-10-20 |
| NO329032B1 NO329032B1 (no) | 2010-08-02 |
Family
ID=9525640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005290A NO329032B1 (no) | 1998-04-24 | 2000-10-20 | Kombinasjon av riluzol- og levodopa samt anvendelse derav |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6387936B1 (no) |
| EP (1) | EP1071422B1 (no) |
| JP (1) | JP2002512963A (no) |
| KR (1) | KR100597170B1 (no) |
| AT (1) | ATE386520T1 (no) |
| AU (1) | AU768069B2 (no) |
| CA (1) | CA2329636C (no) |
| CY (1) | CY1110448T1 (no) |
| CZ (1) | CZ300825B6 (no) |
| DE (1) | DE69938179T2 (no) |
| DK (1) | DK1071422T3 (no) |
| ES (1) | ES2300141T3 (no) |
| FR (1) | FR2777781B1 (no) |
| HU (1) | HU228902B1 (no) |
| IL (1) | IL139164A (no) |
| NO (1) | NO329032B1 (no) |
| PT (1) | PT1071422E (no) |
| RU (1) | RU2225204C2 (no) |
| SK (1) | SK285531B6 (no) |
| UA (1) | UA70319C2 (no) |
| WO (1) | WO1999055336A1 (no) |
| ZA (1) | ZA200005758B (no) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2786101B1 (fr) * | 1998-11-24 | 2002-07-05 | Aventis Laboratoire | Utilisation de la nicergoline dans le traitement de la spasticite |
| US6872739B1 (en) * | 1999-06-04 | 2005-03-29 | Vereniging Voor Christelijk Wetenshappelikjk Onderwijs | Use of riluzole for the treatment of multiple sclerosis |
| GB0007193D0 (en) * | 2000-03-25 | 2000-05-17 | Univ Manchester | Treatment of movrmrnt disorders |
| US20060105036A1 (en) | 2003-05-12 | 2006-05-18 | Stephen Peroutka | Threo-dops controlled release formulation |
| US8158149B2 (en) * | 2004-05-12 | 2012-04-17 | Chelsea Therapeutics, Inc. | Threo-DOPS controlled release formulation |
| US20070010584A1 (en) * | 2003-09-04 | 2007-01-11 | Peroutka Stephen J | Compositions and methods for orthostatic intolerance |
| EP1751312A4 (en) * | 2004-05-21 | 2010-01-27 | Univ Duke | POLYMORPHISM IN TRYPTOPHAN HYDROXYLASE 2 REGULATING BRAIN SEROTONIN SYNTHESIS |
| SE0401842D0 (sv) * | 2004-07-12 | 2004-07-12 | Dizlin Medical Design Ab | Infusion and injection solution of levodopa |
| ES2395555T3 (es) * | 2004-11-07 | 2013-02-13 | Your Energy Systems, LLC | Formulación liposomal para la administración oral de glutatión (reducido) |
| GB0504103D0 (en) * | 2005-02-28 | 2005-04-06 | Syngenta Ltd | Novel method |
| EP1901720A2 (en) * | 2005-06-23 | 2008-03-26 | Spherics, Inc. | Improved dosage forms for movement disorder treatment |
| US20080131492A1 (en) * | 2006-06-23 | 2008-06-05 | Spherics, Inc. | Dosage forms for movement disorder treatment |
| HRP20120479T1 (hr) * | 2006-06-28 | 2012-07-31 | Chelsea@Therapeutics@Inc | Farmaceutski sastavi sa droksidopom |
| CA2673511A1 (en) * | 2006-12-22 | 2008-07-03 | Combinatorx, Incorporated | Pharmaceutical compositions for treatment of parkinson's disease and related disorders |
| AU2008226541B2 (en) * | 2007-03-09 | 2013-05-09 | Chelsea Therapeutics, Inc. | Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgia |
| ES2431570T3 (es) * | 2007-05-07 | 2013-11-27 | Chelsea Therapeutics, Inc. | Droxidopa y composición farmacéutica de la misma para el tratamiento de los trastornos por déficit de atención |
| WO2010000763A2 (en) * | 2008-06-30 | 2010-01-07 | Novartis Ag | Combination products |
| CN102395595A (zh) * | 2008-11-06 | 2012-03-28 | 生物链接治疗股份有限公司 | 不宁腿综合症和睡眠障碍的治疗 |
| EP2228054A1 (en) * | 2009-03-13 | 2010-09-15 | ITALFARMACO S.p.A. | Riluzole aqueous suspensions |
| WO2012054815A1 (en) | 2010-10-22 | 2012-04-26 | Duke University | Slow-release formulations of 5-hydroxytryptophan as an adjunct to pro-serotonergic therapies |
| JP5880913B2 (ja) | 2011-05-17 | 2016-03-09 | 三郎 佐古田 | パーキンソン病の体幹症状(姿勢反射異常)の治療剤 |
| US9463186B2 (en) | 2013-04-15 | 2016-10-11 | Northwestern University | Treatment for dopaminergic disorders |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2700117B1 (fr) * | 1993-01-07 | 1995-02-03 | Rhone Poulenc Rorer Sa | Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens. |
| RU2057529C1 (ru) * | 1994-05-30 | 1996-04-10 | Алексей Михайлович Коршунов | Способ лечения синдрома паркинсонизма |
-
1998
- 1998-04-24 FR FR9805153A patent/FR2777781B1/fr not_active Expired - Fee Related
-
1999
- 1999-04-22 IL IL13916499A patent/IL139164A/xx not_active IP Right Cessation
- 1999-04-22 AT AT99915809T patent/ATE386520T1/de active
- 1999-04-22 JP JP2000545534A patent/JP2002512963A/ja not_active Withdrawn
- 1999-04-22 KR KR1020007011786A patent/KR100597170B1/ko not_active Expired - Fee Related
- 1999-04-22 HU HU0101645A patent/HU228902B1/hu not_active IP Right Cessation
- 1999-04-22 UA UA2000105983A patent/UA70319C2/uk unknown
- 1999-04-22 AU AU34255/99A patent/AU768069B2/en not_active Ceased
- 1999-04-22 DK DK99915809T patent/DK1071422T3/da active
- 1999-04-22 CZ CZ20003908A patent/CZ300825B6/cs not_active IP Right Cessation
- 1999-04-22 PT PT99915809T patent/PT1071422E/pt unknown
- 1999-04-22 RU RU2000129121/15A patent/RU2225204C2/ru not_active IP Right Cessation
- 1999-04-22 SK SK1588-2000A patent/SK285531B6/sk not_active IP Right Cessation
- 1999-04-22 DE DE69938179T patent/DE69938179T2/de not_active Expired - Lifetime
- 1999-04-22 CA CA002329636A patent/CA2329636C/fr not_active Expired - Fee Related
- 1999-04-22 WO PCT/FR1999/000953 patent/WO1999055336A1/fr not_active Ceased
- 1999-04-22 EP EP99915809A patent/EP1071422B1/fr not_active Expired - Lifetime
- 1999-04-22 ES ES99915809T patent/ES2300141T3/es not_active Expired - Lifetime
-
2000
- 2000-10-17 ZA ZA200005758A patent/ZA200005758B/en unknown
- 2000-10-20 NO NO20005290A patent/NO329032B1/no not_active IP Right Cessation
- 2000-10-24 US US09/694,860 patent/US6387936B1/en not_active Expired - Lifetime
-
2008
- 2008-04-24 CY CY20081100457T patent/CY1110448T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20005290D0 (no) | 2000-10-20 |
| CA2329636C (fr) | 2009-09-08 |
| DK1071422T3 (da) | 2008-06-16 |
| ZA200005758B (en) | 2002-01-17 |
| ES2300141T3 (es) | 2008-06-01 |
| SK285531B6 (sk) | 2007-03-01 |
| IL139164A0 (en) | 2001-11-25 |
| WO1999055336A1 (fr) | 1999-11-04 |
| RU2225204C2 (ru) | 2004-03-10 |
| AU768069B2 (en) | 2003-12-04 |
| HUP0101645A3 (en) | 2002-10-28 |
| DE69938179T2 (de) | 2009-02-12 |
| PT1071422E (pt) | 2008-05-05 |
| EP1071422B1 (fr) | 2008-02-20 |
| HUP0101645A2 (hu) | 2001-09-28 |
| ATE386520T1 (de) | 2008-03-15 |
| CZ300825B6 (cs) | 2009-08-19 |
| KR100597170B1 (ko) | 2006-07-05 |
| NO329032B1 (no) | 2010-08-02 |
| CY1110448T1 (el) | 2015-04-29 |
| JP2002512963A (ja) | 2002-05-08 |
| EP1071422A1 (fr) | 2001-01-31 |
| KR20010042960A (ko) | 2001-05-25 |
| AU3425599A (en) | 1999-11-16 |
| CZ20003908A3 (cs) | 2001-02-14 |
| SK15882000A3 (sk) | 2001-04-09 |
| CA2329636A1 (fr) | 1999-11-04 |
| FR2777781A1 (fr) | 1999-10-29 |
| HU228902B1 (en) | 2013-06-28 |
| DE69938179D1 (de) | 2008-04-03 |
| FR2777781B1 (fr) | 2004-04-09 |
| US6387936B1 (en) | 2002-05-14 |
| IL139164A (en) | 2005-12-18 |
| UA70319C2 (en) | 2004-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20005290D0 (no) | Riluzol- og levodopa kombinasjoner for behandling av Parkinsons sykdom | |
| GB0108592D0 (en) | Therapeutic agents | |
| CY2018020I1 (el) | Θεραπεια της νοσου ρομρε | |
| PL310475A1 (en) | Application of anticonvulsants in treating neuro-aids diseases | |
| ATE346039T1 (de) | Sulfonamido-substituierte verbrückte bicycloalkylderivative | |
| BG106450A (en) | Use of retigabin for treating neuropathic pain | |
| SI1303272T1 (sl) | Derivati benzotiazola za zdravljenje alzheimerjeve bolezni in parkinsonove bolezni | |
| FI20000720L (fi) | Pitkitettyyn vapautumiseen perustuva tablettiformulaatio Parkisonin taudin hoitamiseksi | |
| NO20001869D0 (no) | Fremgangsmõte for behandling av Alzheimerssykdom | |
| DE69832695D1 (de) | Verwendung von r-enantiomeren nichtsteroidaler entzündungshemmer zur vorbeugung der alzheimerschen krankheit | |
| ES2177024T3 (es) | Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer. | |
| DK1133296T3 (da) | Ny terapeutisk anvendelse af nicergolin | |
| HUP9904029A3 (en) | Use of 2-(3,4-dimethoxycinnamoyl)aminobenzoic acid for the manufacture of a medicament for the treatment or prevention of restenosis | |
| EA200000816A1 (ru) | Применение 2-амино-6-трифторметоксибензотиазола для профилактики или лечения дисфункции мозжечка | |
| DK1133297T3 (da) | Ny terapeutisk anvendelse af 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin | |
| AU2003287513A8 (en) | Inhibitors of beta-secretase, and their use for the prevention or treatment of alzheimer's disease or mild cognitive impairment | |
| ATE323486T1 (de) | Verwendung des riluzols oder dessen salzen zur phophylaxe und behandlung der adrenoleukodystrophie | |
| NO970190D0 (no) | Preparat til behandling av Parkinsons sykdom |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |